🇺🇸 Phase C: Torasemide in United States

Phase C: Torasemide (Phase C: Torasemide) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

Phase C: Torasemide in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Phase C: Torasemide approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Phase C: Torasemide in United States?

National Institute of Cardiology, Warsaw, Poland is the originator. The local marketing authorisation holder may differ — check the official source linked above.